BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 32320664)

  • 1. IL-33-PU.1 Transcriptome Reprogramming Drives Functional State Transition and Clearance Activity of Microglia in Alzheimer's Disease.
    Lau SF; Chen C; Fu WY; Qu JY; Cheung TH; Fu AKY; Ip NY
    Cell Rep; 2020 Apr; 31(3):107530. PubMed ID: 32320664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response.
    Pimenova AA; Herbinet M; Gupta I; Machlovi SI; Bowles KR; Marcora E; Goate AM
    Neurobiol Dis; 2021 Jan; 148():105217. PubMed ID: 33301878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer's disease pathology.
    Lau SF; Wu W; Wong HY; Ouyang L; Qiao Y; Xu J; Lau JH; Wong C; Jiang Y; Holtzman DM; Fu AKY; Ip NY
    Nat Aging; 2023 Oct; 3(10):1219-1236. PubMed ID: 37735240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
    Hickman SE; Allison EK; El Khoury J
    J Neurosci; 2008 Aug; 28(33):8354-60. PubMed ID: 18701698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ.
    Jo KW; Lee D; Cha DG; Oh E; Choi YH; Kim S; Park ES; Kim JK; Kim KT
    Alzheimers Res Ther; 2022 Oct; 14(1):158. PubMed ID: 36271414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PU.1 regulates Alzheimer's disease-associated genes in primary human microglia.
    Rustenhoven J; Smith AM; Smyth LC; Jansson D; Scotter EL; Swanson MEV; Aalderink M; Coppieters N; Narayan P; Handley R; Overall C; Park TIH; Schweder P; Heppner P; Curtis MA; Faull RLM; Dragunow M
    Mol Neurodegener; 2018 Aug; 13(1):44. PubMed ID: 30124174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
    Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of transcriptome remodeling in plaque-associated and plaque-distant microglia during amyloid-β pathology progression in mice.
    Hemonnot-Girard AL; Meersseman C; Pastore M; Garcia V; Linck N; Rey C; Chebbi A; Jeanneteau F; Ginsberg SD; Lachuer J; Reynes C; Rassendren F; Hirbec H
    J Neuroinflammation; 2022 Sep; 19(1):234. PubMed ID: 36153535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer's Disease (Mouse Model) through Autophagy Induced by Activating Axl.
    Qi LF; Liu S; Liu YC; Li P; Xu X
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial amyloid beta clearance is driven by PIEZO1 channels.
    Jäntti H; Sitnikova V; Ishchenko Y; Shakirzyanova A; Giudice L; Ugidos IF; Gómez-Budia M; Korvenlaita N; Ohtonen S; Belaya I; Fazaludeen F; Mikhailov N; Gotkiewicz M; Ketola K; Lehtonen Š; Koistinaho J; Kanninen KM; Hernández D; Pébay A; Giugno R; Korhonen P; Giniatullin R; Malm T
    J Neuroinflammation; 2022 Jun; 19(1):147. PubMed ID: 35706029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer's Disease: A Targeted Transcriptome Analysis.
    Ma C; Hunt JB; Kovalenko A; Liang H; Selenica MB; Orr MB; Zhang B; Gensel JC; Feola DJ; Gordon MN; Morgan D; Bickford PC; Lee DC
    Front Immunol; 2021; 12():628156. PubMed ID: 34046031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium rutin ameliorates Alzheimer's disease-like pathology by enhancing microglial amyloid-β clearance.
    Pan RY; Ma J; Kong XX; Wang XF; Li SS; Qi XL; Yan YH; Cheng J; Liu Q; Jin W; Tan CH; Yuan Z
    Sci Adv; 2019 Feb; 5(2):eaau6328. PubMed ID: 30820451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.
    Kitazawa M; Hsu HW; Medeiros R
    Toxicol Sci; 2016 Jul; 152(1):194-204. PubMed ID: 27122238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Amyloid Burden by Proliferated Homeostatic Microglia in
    Shin JH; Hwang YS; Jung BK; Seo SH; Ham DW; Shin EH
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.